Insight

Harold Burstein: Thoughtful op-ed on multicancer ctDNA genomic screens by Hilary Robbins

Collage photo of Harold Burstein and Hilary Robbins

Aug 1, 2024, 15:35

Harold Burstein: Thoughtful op-ed on multicancer ctDNA genomic screens by Hilary Robbins

Harold Burstein, Breast cancer specialist and Professor at Dana Farber Cancer Institute, shared a post on X about a recent paper by Hilary Robbins titled “Multicancer Early Detection Tests — Keeping a High Bar for Evidence of Benefit” published in The New England Journal of Medicine.

“Thoughtful op-ed on multicancer ctDNA genomic screens. Issues of false-reassurance, and on other side, positives without clinical cancers, are important to address.”

Source: Harold Burstein/X

cancer ctDNA genomic screens Dana-Farber Cancer Institute Early Detection Tests Harold Burstein Hilary Robbins Multicancer New England Journal of Medicine OncoDaily Oncology

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage